LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 93 filers reported holding LION BIOTECHNOLOGIES INC in Q3 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $26,578,000 | +7.2% | 3,567,553 | 0.0% | 1.51% | -14.1% |
| Q4 2016 | $24,794,000 | -15.6% | 3,567,553 | 0.0% | 1.76% | -7.0% |
| Q3 2016 | $29,360,000 | +0.4% | 3,567,553 | -1.2% | 1.90% | -6.6% |
| Q2 2016 | $29,257,000 | +106.6% | 3,611,976 | +29.6% | 2.03% | +63.3% |
| Q1 2016 | $14,159,000 | -38.9% | 2,787,256 | -7.1% | 1.24% | -27.5% |
| Q4 2015 | $23,161,000 | -32.0% | 3,000,161 | -49.2% | 1.71% | +26.0% |
| Q3 2015 | $34,046,000 | +34.5% | 5,910,912 | +114.2% | 1.36% | -10.8% |
| Q2 2015 | $25,305,000 | -23.0% | 2,759,593 | +1.7% | 1.52% | -40.4% |
| Q1 2015 | $32,873,000 | +29.9% | 2,714,549 | -15.6% | 2.56% | +20.4% |
| Q4 2014 | $25,298,000 | +21.4% | 3,214,549 | +10.3% | 2.12% | -5.2% |
| Q3 2014 | $20,839,000 | +8.1% | 2,914,549 | -3.2% | 2.24% | +18.4% |
| Q2 2014 | $19,273,000 | -31.9% | 3,011,549 | +0.4% | 1.89% | -36.5% |
| Q1 2014 | $28,320,000 | – | 3,000,000 | – | 2.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|